doi: 10.1016/j.lfs.2020.118548 [DOI] [PMC free article] [PubMed] [Google Scholar] 177.Saengboonmee C, Sorin S, Sangkhamanon S, et al
Entrambe le formulazioni agiscono come agonisti del recettore del GLP-1 , un ormone incretinico che regola la secrezione insulinica in modo glucosio-dipendente, riduce la secrezione di glucagone, rallenta lo svuotamento gastrico e contribuisce al controllo dellappetito
Moreover, DTCM-g demonstrated radiosensitization capabilities in glioblastoma, 50,51 further emphasizing its potential as a valuable therapeutic drug in radiotherapy
This highlights the ongoing need for accessible, non-invasive biomarkers that can aid in the timely detection, accurate diagnosis, and monitoring of disease progression and future treatment response